Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-02-11

Clinical Trial Update: Phase II Study of Oxaliplatin in Combination With 5-Fu in 1st Line Treatment of Locally Advanced or Metastatic Squamous Cell Carcinoma of the Head and Neck [Phase 2]

View source ↗

Summary

This completed Phase II trial evaluated oxaliplatin in combination with 5-fluorouracil as first-line therapy for locally advanced or metastatic squamous cell ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Adrucil (5-fluorouracil)
  • Eloxatin (oxaliplatin)

Snippet

Sponsor: Sanofi | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED